The 30 references in paper I. Vilyum A., B. Andreev V., M. Proskurin A., Yu. Balykina E., И. Вилюм А., Б. Андреев В., М. Проскурин А., Ю. Балыкина Е. (2018) “Фармакоэкономический анализ классических и атипичных лекарственных препаратов в лечении шизофрении // Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia” / spz:neicon:pharmacoeconomics:y:2018:i:2:p:9-24

1
Gurovich I. Ya., Lyubov E. B. Pharmacoepidemiology and pharmacoeconomics in psychiatry [Farmakoehpidemiologiya i farmakoehkonomika v psihiatrii (in Russian)]. Moscow. 2003; 264 s.
(check this in PDF content)
2
Gurovich I. Ya., Lyubov E. B. et al. Social’naya i klinicheskaya psihiatriya (in Russian). 2002; 12 (3): 46-55.
(check this in PDF content)
3
Rise D. P. Economic burden of mental disorders in the USA. econom.neurosc. 1999; I: 40-44.
(check this in PDF content)
4
YAstrebov V.S. et al. Social’naya i klinicheskaya psihitariya (in Russian). 2009; 19 (4): 21-28.
(check this in PDF content)
5
Belousov Yu.B. et al. Psihiatriya i farmakoterapiya (in Russian). 2007; 9 (4): 49-55.
(check this in PDF content)
6
Belousov Yu.B. et al. kachestvennaya klinicheskaya praktika (in Russian). 2011; 1: 51-57.
(check this in PDF content)
7
Krysanov I. S. et al. Social’naya i klinicheskaya psihiatriya (in Russian). 2017; 27 (2): 88-94.
(check this in PDF content)
8
Omel’yanovskij V. V. Social’naya i klinicheskaya psihiatriya (in Russian). 2013; 23 (2): 73-83.
(check this in PDF content)
9
Krysanov I. S. et al. kachestvennaya klinicheskaya praktika (in Russian). 2016; 4: 27-34.
(check this in PDF content)
10
Etobaeva I. G., Lubsanova S. A., Tyheeva N. A., Rodnaeva O. A. Sovremennye problemy nauki i obrazovaniya (in Russian). 2015; 1(1): 13-24.
(check this in PDF content)
11
Krot K. V. et al. kachestvennaya klinicheskaya praktika (in Russian). 2016; 1: 34-40.
(check this in PDF content)
12
Janicak P. G. The CATIE study and its implications antipsychotic drug use. essent Psychopharmacol. 2006; 7: 53-63.
(check this in PDF content)
13
Kahn R. S. et al. Effectiveness of antipsychotic drugs in firstepisode schizophrenia an schizophreniform disorder: an open randomized clinical trial. Lancet. 2008; 371: 1085-97.
(check this in PDF content)
14
Vilyum I. A., Andreev B. V., Proskurin M. A., Balykina YU.E. FARMAkOekOnOMikA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / FARMAkOekOnOMikA. Modern pharmacoeconomics and pharmacoepidemiology (in Russian). 2018; 11 (1): 3-18. https://doi.org/10.17749/2070-4909.2018.11.1.003-018.
(check this in PDF content)
15
Vilyum I. A., Andreev B. V., Proskurin M. A., Balykina Yu. E. klinicheskaya farmakologiya i terapiya (in Russian). 2018; 27 (2): 69-76.
(check this in PDF content)
16
On the approval of the industry standard “clinical and economic research. General provisions”: Order No. 161 of the Ministry of Health of the Russian Federation of 27.05.2011 [Ob utverzhdenii otraslevogo standarta «kliniko-ehkonomicheskie issledovaniya. Obshchie polozheniya»: prikaz No163 Ministerstva Zdravoohraneniya Rossijskoj Federacii ot 27.05.2011 (in Russian)].
(check this in PDF content)
17
Avksent’eva M.A., Gerasimov B. V., Sura M. V. Clinical and economic analysis (assessment, selection of medical technologies and quality management of medical care). Ed. P. A. Vorobyov [klinikoehkonomicheskij analiz (ocenka, vybor medicinskih tekhnologij i upravleniya kachestvom medicinskoj pomoshchi). Pod red. P. A. Vorob’eva (in Russian)]. Moscow. 2004; 404 s.
(check this in PDF content)
18
Belousov Yu.B. Planning and conducting clinical trials of medicines [Planirovanie i provedenie klinicheskih issledovanij lekarstvennyh sredstv (in Russian)]. Moscow. 2000; 579 s.
(check this in PDF content)
19
Basic concepts in the evaluation of medical technologies: a method. allowance. Under. Ed. AS Kolbin, SK Zyryanov, D. Yu. Belousov [Osnovnye ponyatiya v ocenke medicinskih tekhnologij: metod. posobie. Pod. red. A. S. kolbina, S. k. Zyryanova, D. YU. Belousova (in Russian)]. Moscow. 2013; 42 s.
(check this in PDF content)
20
Walley T., Haycox A., Boland A. Pharmacoeconomics. elsevier Health Sciences. 2004; 216 s.
(check this in PDF content)
21
Josephine A. Mauskopf et al. Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices – Budget Impact Analysis. Value in Health. 2007; 10 (5); 336-347.
(check this in PDF content)
22
Decree of the Government of the Russian Federation of December 12, 2016 N 1403 “On the Program of State Guarantees of Free Medical Assistance to Citizens for 2017 and for the Planning Period of 2018 and 2019” [Postanovlenie Pravitel’stva RF ot 19.12.2016 n 1403 «O Programme gosudarstvennyh garantij besplatnogo okazaniya grazhdanam medicinskoj pomoshchi na 2017 god i na planovyj period 2018 i 2019 godov» (in Russian)].
(check this in PDF content)
23
The General Tariff Agreement for St. Petersburg (in Russian). [electronic resource] URL: http://www.spboms.ru/kiop/main?page_ id=338. Accessed: 18.04.2018.
(check this in PDF content)
24
State Register of Medicines (in Russian). [electronic resource] URL: http://grls.rosminzdrav.ru/Default.aspx. Accessed: 18.04.2018.
(check this in PDF content)
25
Russian pharmaceutical portal PHARM-index (in Russian). [electronic resource] URL: https://www.pharmindex.ru/. Accessed: 18.04.2018.
(check this in PDF content)
26
Federal Law No. 255-FZ of December 29, 2006 (as amended on 03.12.2011) “On compulsory social insurance in case of temporary incapacity for work and in connection with maternity” [Federal’nyj zakon ot 29.12.2006 n 255-FZ (red. ot 03.12.2011) «Ob obyazatel’nom social’nom strahovanii na sluchaj vremennoj netrudosposobnosti i v svyazi s materinstvom» (in Russian)].
(check this in PDF content)
27
The territorial department of the Federal State Statistics Service for St. Petersburg and the Leningrad region, the official website (in Russian). [electronic resource] URL: http://petrostat.gks.ru/. Accessed: 18.04.2018.
(check this in PDF content)
28
Lekht S. et al. Social’naya i klinicheskaya psihitariya (in Russian). 2016; 26 (2): 65-71.
(check this in PDF content)
29
Davis J. M. et al. A meta-analysis of efficacy of secondgeneration antipsychotics. Arch. Gen. Psychiatry. 2003; 60: 733-759.
(check this in PDF content)
30
Newton A. S. Antipsychotics in adult with schizophrenia: comparative effectiveness of fist-generation versus second-generation medications a systematic review and meta-analysis. Ann. int. Med. 2012; 157: 498-511. Сведения об авторах:
(check this in PDF content)